EGFR and neoplasm: Figure 9A and Figure 9B indicate that no matter the response of the tumor (CR, PR, SD, or PD), miR-107 and miR-195 expression levels at the time of PD exhibit a tendency to return to the levels before EGFR-TKI treatment in the majority of patients.